ClinConnect ClinConnect Logo
Search / Trial NCT06086184

Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder

Launched by VIVANTES NETZWERK FÜR GESUNDHEIT GMBH · Oct 12, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Mindfulness Acceptance And Commitment Therapy Psychotherapy, Group Inpatients Psychotic Disorders

ClinConnect Summary

This clinical trial is exploring a new treatment called Group Acceptance and Commitment Therapy (ACT) for patients with psychotic disorders, such as schizophrenia or delusional disorder. The goal is to see if this group therapy can help patients better manage their symptoms, feel more satisfied with their treatment, and reduce the chances of needing to return to the hospital. The trial is currently recruiting participants aged 18 and older who have been diagnosed with one of the specific psychotic disorders.

If you or someone you know is considering joining, participants will take part in group therapy sessions designed to help them accept their experiences and develop a positive approach to their treatment. To be eligible, participants must have a diagnosis from a list that includes various types of psychotic disorders and should be able to understand and communicate during the sessions. It’s important to note that those who do not wish to participate or have difficulties with language or understanding may not be eligible. Overall, this trial could provide valuable insights into how group therapy can support individuals facing these challenging conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with psychosis spectrum disorder with the following diagnoses according to the Diagnostic and Statistical Manual Diploma in Social Medicine 5 ("Schizophrenia Spectrum and Other Psychotic Disorders"):
  • Schizophrenia
  • Schizophreniform disorder
  • Schizoaffective disorder
  • Delusional disorder
  • Brief psychotic disorder
  • Psychotic disorder due to another disorder
  • Substance-induced/medication-induced psychotic disorder
  • Depressive episode with psychotic symptoms
  • Manic or bipolar episode with psychotic symptoms
  • Exclusion Criteria:
  • Patients decline to participate in the treatment program
  • Language or intellectual abilities insufficient for study participation

About Vivantes Netzwerk Für Gesundheit Gmbh

Vivantes Netzwerk für Gesundheit GmbH is a leading healthcare provider based in Berlin, Germany, dedicated to delivering high-quality medical services and advancing clinical research. With a network of multiple hospitals and specialized facilities, Vivantes focuses on patient-centered care while fostering innovation in medical treatments and therapies. The organization is committed to conducting rigorous clinical trials that contribute to the advancement of medical knowledge and improve health outcomes, collaborating with various stakeholders to ensure the highest standards of research integrity and ethical practices.

Locations

Berlin Kreuzberg, Berlin, Germany

Patients applied

0 patients applied

Trial Officials

Andreas Bechdolf, Prof. Dr.

Study Director

Senior consultant department of psychiatry Vivantes Klinikum Am Urban and Klinikum im Friedrichshain

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported